Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
AIDS Research and Human Retroviruses|September 22, 2010
Beyond 2010: Gaps, Challenges, and Priorities for the Future of Preclinical HIV Preexposure Prophylaxis (PrEP): Summary of the October 20-21, 2009 WorkshopFulvia Veronese, Jim A Turpin, Cindra Feuer
Current HIV/AIDS Reports|October 7, 2014
Role of oral pre-exposure prophylaxis (PrEP) in current and future HIV prevention strategiesDavid N Burns, Cynthia Grossman, Jim Turpin, et al.
AIDS Research and Human Retroviruses|April 26, 2013
Pharmacokinetics and pharmacodynamics in HIV prevention; current status and future directions: a summary of the DAIDS and BMGF sponsored think tank on pharmacokinetics (PK)/pharmacodynamics (PD) in HIV preventionJoseph Romano, Angela Kashuba, Stephen Becker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2005
In vitro and in vivo: the story of nonoxynol 9Sharon L Hillier, Thomas Moench, Robin Shattock, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 13, 2002
Does patient sex affect human immunodeficiency virus levels?Monica Gandhi, Peter Bacchetti, Paolo Miotti, et al.
AIDS Research and Human Retroviruses|October 26, 2010
Implications of HIV PrEP trials resultsFulvia Veronese, Peter Anton, Courtney V Fletcher, et al.
Health Marketing Quarterly|December 13, 2021
Market segmentation of South African adolescent girls and young women to inform HIV prevention product marketing strategy: A mixed methods studyKenyon Crowley, Michelle Dugas, Guodong Gordon Gao, et al.
AIDS Research and Human Retroviruses|October 12, 2016
Understanding the Intersection of Young Age, Mucosal Injury, and HIV SusceptibilityKristen A Porter, Jim Turpin, Lisa Begg, et al.
AIDS Research and Human Retroviruses|September 8, 2012
Greentree white paper: sexual violence, genitoanal injury, and HIV: priorities for research, policy, and practiceJennifer F Klot, Judith D Auerbach, Fulvia Veronese, et al.
Scientific Reports|February 2, 2017
Predicting HIV Pre-exposure Prophylaxis Efficacy for Women using a Preclinical Pharmacokinetic-Pharmacodynamic In Vivo ModelAngela Wahl, Phong T Ho, Paul W Denton, et al.
Pageof 2